The amygdala is a region of the brain involved in assinging emotional salience to our sensory world. Disorders of amygdala function lead to a range of anxiety related disorders. In this grant we aim to understand the neural circuits that are invovled in one form of learning that engages the amygdala - fear conditioning.
Function And Physiological Role Of Inhibitory Circuits In The Amygdala
Funder
National Health and Medical Research Council
Funding Amount
$741,518.00
Summary
The amygdala is part of the brain that assigns emotional content to our sensory world and dysfunction of the amygdala is responsible for many anxiety-related disorders. Many anxiolytics, like valium, act on receptors in the amygdala. In this project we will study circuits in the amygdala that are modulated by anxiolytics. These studies will provide essential information in the understanding of anxiety disorders and help in developing drugs to treat these disorders.
Dynamic Trafficking Of Amino Acid Transporters At Synapses And Their Role In Regulating Neurotransmission
Funder
National Health and Medical Research Council
Funding Amount
$421,219.00
Summary
Brain cells release chemical neurotransmitters to activate their neighbours. The most abundant neurotransmitter is glutamate, which mediates most of the communication in the brain. Following release, this neurotransmitter must be rapidly recycled to prevent levels being depleted and neurotransmission failing. The subject of this grant is to understand what molecules and pathways are used to recycle glutamate in the brain, and how its supply is controlled to sustain continual brain activation.
The Impact Of The Changes In Levels Of Adhesion Molecules NCAM2 And DsCAM On Synapse Formation And Function: Implications For Down Syndrome
Funder
National Health and Medical Research Council
Funding Amount
$334,053.00
Summary
Down syndrome (DS) results from triplication of chromosome 21 and leads to mental retardation, molecular mechanisms of which are not understood. We found that two proteins, NCAM2 and DSCAM, encoded at chromosome 21 are highly expressed in synapses. Synapses are specialized contacts between neurons which allow neurons to process information in the brain. In this project we will test a hypothesis that changes in NCAM2 and DSCAM expression result in synapse abnormalities observed in DS.
Novel Pathomechanisms And Treatment Approaches In Alzheimer’s Disease And Related Forms Of Dementia
Funder
National Health and Medical Research Council
Funding Amount
$774,540.00
Summary
This fellowship will provide new insight into the molecular processes underlying onset and progression of common brain conditions, including Alzheimer’s disease, Frontotemporal dementia and Motor Neuron Disease. Furthermore, new therapeutic targets for these diseases will be developed and tested in model systems, to facilitate future translation into clinical application, and to overcome the lack of treatments.
SEZ6 AND NEURONAL CALCIUM SIGNALLING IN SYNAPSE DEVELOPMENT
Funder
National Health and Medical Research Council
Funding Amount
$617,685.00
Summary
Inappropriate development and function of neuronal circuits is a universal feature of neurological disorders of cognition such as Down syndrome, autism spectrum disorders and Fragile X mental retardation, epilepsy, schizophrenia and Alzheimer�s disease. In these diseases, neurons exhibit abnormal neuronal branches (dendrites) and abnormal connections on dendritic spines. This research is aimed at understanding the mechanisms controlling dendrite development that underpin proper neuronal wiring.